Mitotic proteins are attractive targets to develop molecular cancer therapeutics due to the intimate interdependence between cell proliferation and mitosis. In this work, we have explored the therapeutic potential of the kinetochore (KT) protein Hec1 (Highly Expressed in Cancer protein 1) as a molecular target to produce massive chromosome missegregation and cell death in cancer cells. Hec1 is a constituent of the Ndc80 complex, which mediates KT-microtubule (MT) attachments at mitosis and is upregulated in various cancer types. We expressed Hec1 fused with enhanced green fluorescent protein (EGFP) at its N-terminus MT-interaction domain in HeLa cells and showed that expression of this modified Hec1, which localized at KTs, blocked cell proliferation and promoted apoptosis in tumour cells. EGFP-Hec1 was extremely potent in tumour cell killing and more efficient than siRNA-induced Hec1 depletion. In striking contrast, normal cells showed no apparent cell proliferation defects or cell death following EGFP-Hec1 expression. Live-cell imaging demonstrated that cancer cell death was associated with massive chromosome missegregation within multipolar spindles after a prolonged mitotic arrest. Moreover, EGFP-Hec1 expression was found to increase KT-MT attachment stability, providing a molecular explanation for the abnormal spindle architecture and the cytotoxic activity of this modified protein.
INTRODUCTION
Highly Expressed in Cancer protein 1 (Hec1) 1 is a constituent of the evolutionary conserved Ndc80 complex, the primary site of interaction between kinetochores (KTs) and microtubules (MTs). 2 The Ndc80 complex localizes at KTs and is composed of four subunits: Hec1, Nuf2, Spc24, and Spc25. 2 This complex is required for accurate chromosome segregation in mitosis, as it is essential for generating bipolar end-on KT-MT attachments, which are responsible for the faithful anaphase segregation of sister chromatids. 2, 3 Because of the stochastic nature of KT-MT encounters, during the early stages of mitosis erroneous KT-MT interactions frequently occur, which are subsequently modified by a process of error correction. This process is governed by the mitotic kinase aurora B that phosphorylates the Hec1 N-terminal tail 4 and several other substrates that modulate KT-MT attachment stability. [5] [6] [7] [8] HEC1 mRNA is overexpressed in 60 out of the 65 data sets of different human cancer tissues in the Oncomine database (www. oncomine.org), and elevated Hec1 expression is associated with negative prognosis in multiple cancer types. [9] [10] [11] Moreover, HEC1 mRNA and protein are found overexpressed in lung and colorectal cancer cells. 10, 12 The crucial role of the Ndc80 complex in chromosome segregation during mitosis, the recurrent HEC1 upregulation in different human cancers and the dependence of Hec1 upregulation on pRb deficiency 13 suggest that HEC1 deregulation may be an important step in the multistage process of tumorigenesis. Indeed, Hec1 overexpression in an inducible mouse model has been shown to promote chromosome instability in embryonic fibroblasts and tumour formation in different mouse tissues. 14 Compelling evidence has highlighted a double role of chromosome instability in cancer, leading to a model in which low chromosome instability results in a slight growth advantage and/ or tumour promotion and thereby promotes cancer cell transformation, whereas high chromosome instability leads to cell death and acts as a tumour-suppressor mechanism. 15, 16 Consequently, the idea of promoting cell death by inducing massive aneuploidy at mitotic division has been proposed as a therapeutic strategy to selectively eliminate highly proliferating tumour cells. 17, 18 We previously reported that expression of Hec1 fused at its N-terminus-an MT interacting domain-with the enhanced green fluorescent protein (EGFP) tag (EGFP-Hec1) acts as a dominant-negative mutant, disrupting chromosome segregation at mitosis. 19 On the contrary, expression of Hec1 fused at its C-terminus with EGFP (Hec1-EGFP) does not interfere with mitosis, 19 in accordance with the role of Hec1 N-terminal tail in KT-MT attachment stability. 4, 20, 21 We also demonstrated that expression of the EGFP-Hec1 fusion protein in cultured HeLa cells disrupts mitosis by producing persisting lateral KT-MT attachments and multipolar spindles. 19 In light of the association of Hec1 overexpression with cancer and the dominant-negative effect of the modified EGFP-Hec1 protein on the mitotic process, here we have explored Hec1 as a molecular target for cancer therapy, as a means to induce massive chromosome missegregation and cell death in cancer cells. To this aim, we have induced expression of EGFP-Hec1 in cancer cells and showed that it has potent and selective cytotoxic properties against cancer cells both in vitro and in vivo conditions. Finally, we demonstrated that EGFP-Hec1 increases KT-MT attachment stability, suggesting that interference with KT-MT dynamics represents a promising therapeutic target for cancer treatment.
RESULTS

EGFP-Hec1 expression blocks cancer cell proliferation and induces apoptosis
To assess the cytotoxic activity of an N-terminally modified Hec1 protein, an EGFP-Hec1 inducible vector was stably integrated into a single predefined site in Flp-In HeLa cells to obtain a moderate transgene expression. 19 EGFP-Hec1 expression was activated by addition of doxycycline (Supplementary Figure S1a and Mattiuzzo et al. 19 ) and cell proliferation was monitored for 72 h. Induction of EGFP-Hec1 completely abolished HeLa cell growth within 24 h, as shown by phase-contrast observation ( Figure 1a ) and vital cell counting (Figure 1b ). On the contrary, expression of Hec1-EGFP, the modified Hec1 bearing the EGFP tag at the C terminus, did not influence cell growth (Figure 1b and Supplementary Figure S1b ), even though both proteins localized at KTs. 19 These findings demonstrate that the cytotoxic activity of EGFP-Hec1 is dependent on the modification at the N terminus and suggest that it is mediated by a non-functional interaction between the modified N-terminal tail and MTs.
Inactivation of endogenous HEC1 by siRNA has been shown to induce a spindle checkpoint-dependent mitotic arrest 22, 23 and has been proposed as a strategy to kill tumour cells. 24, 25 Therefore, induction of cell death following expression of EGFP-Hec1 was assayed in comparison with HEC1 inactivation through RNA silencing. As predicted, Hec1 depletion produced a clear inhibition in cell proliferation (Figures 1c and d ). However, growth inhibition never reached the complete proliferation arrest observed in EGFP-Hec1 cells, although Hec1 was efficiently depleted in the silenced samples (Supplementary Figure S1c) . We then investigated cell cycle perturbations and cell death by flow cytometry. EGFP-Hec1 efficiently arrested cells in the G2/M phases of the cell cycle 24 h from doxycycline addition and induced massive DNA fragmentation at later times (Figures 2a and b ), suggesting that cells were arrested in mitosis upon EGFP-Hec1 expression and then died. Conversely, Hec1 depletion by siRNA was much less efficient in promoting cell cycle arrest and death. Twenty four hours after HEC1 silencing, the G2/M fraction was approximately 50% of the cell population, and about 20% of the cells exhibited an hypodiploid DNA content at 72 h (Figures 2c and d ). For comparison, at that time 70% of EGFP-Hec1 cells had a sub-G1 DNA content. In agreement with the cell proliferation data, expression of Hec1-EGFP neither altered cell cycle progression nor induced cell death (Supplementary Figure S2 ). Western blotting analysis of apoptosis mediators demonstrated that EGFP-Hec1induced cell death was due to apoptosis, as determined by the strong cleavage of the DNA repair protein PARP (poly ADP-ribose polymerase) and the presence of the cleaved form of the proapoptotic mediator caspase 3 (Figure 2e ). In accordance with the milder death phenotype observed after Hec1 depletion, apoptosis mediators were activated to a lower extent in the silenced cells, although Hec1 depletion was nearly complete in the siRNAtreated samples ( Figure 2f ). Altogether, these findings demonstrate that EGFP-Hec1 expression is a potent inducer of apoptotic death in tumour cultured cells.
Multipolar spindles induced by EGFP-Hec1 expression kill tumour cells by triggering mitotic catastrophe
Immunofluorescence analysis of the mitotic population was then performed in order to accurately define the mitotic phenotypes elicited by EGFP-Hec1 expression or Hec1 depletion. Upon EGFP-Hec1 expression, multipolar mitotic spindles frequently formed, so that approximately half of the mitoses possessed more than two poles (Figures 3a and b ). On the contrary, Hec1 silenced mitoses were characterized by lack of Hec1 from KTs and exhibited mostly bipolar spindles (Figures 3c and d ). Furthermore, chromosomes were organized in an early prometaphase configuration without observable metaphase plate, due to the absence of Hec1-mediated KT-MT interactions (Figure 3c ).
To assess the fate of mitoses with multipolar spindles, we followed EGFP-Hec1-expressing H2B-EGFP-transfected cells by time-lapse microscopy. Whereas uninduced cells rapidly completed chromosome congression, entered anaphase shortly thereafter and reattached to the substrate within a time interval of approximately 1 h (Figures 4a and d , Supplementary videos S1 and S2), EGFP-Hec1-expressing cells experienced a dramatic prometaphase delay (mean prometaphase duration 320 ± 29.8 min), and chromosomes failed to maintain alignment at the metaphase plate. Indeed, most chromosomes initially congressed into a bipolar metaphase plate and stayed in that state for a variable amount of time before moving abruptly toward the poles, suggesting that cohesion at centromeres was unable to resist MT-dependent forces. 26, 27 After a variable time, chromosomes displayed a 'Y'-type alignment, indicative of spindle multipolarity. Attempted chromosome segregation, plasma membrane contraction and nuclear blebbing then followed (Figure 4b , Supplementary videos S3 and S4). These mitotic events were observed in about 50% of mitoses, whereas in the other half chromosome alignment, re-dispersion and chromosome segregation attempts occurred within a bipolar spindle ( Figure 4c ). Analysis of time-lapse recordings showed that approximately 75% of EGFP-Hec1 mitoses died by apoptosis directly from mitosis. Less than 20% underwent chromosome segregation within a multipolar anaphase, resulting in multinucleated interphase cells, and a fraction of these (50%) subsequently died in interphase. Finally, in about 5% of the cells cytokinesis failed after chromosome segregation ( Figure 4e ). All these death phenotypes present morphological traits associated with mitotic catastrophe, 28 suggesting that mitotic catastrophe drives cell death after EGFP-Hec1 expression.
EGFP-Hec1 stabilizes KT-MT attachments
Previous work demonstrated that KTs harbouring EGFP-Hec1 form persistent lateral KT-MT interactions that retain the plus-end kinesin CENP-E. 19 To test directly whether EGFP-Hec1 expression affects KT-MT attachment dynamics, we performed measurements of MT flux rates and turnover 29 in Hec1-EGFP or EGFP-Hec1 Hela cells after transfection with a vector-expressing α-tubulin fused to the photoconvertible fluorescent protein mEos2. 30 MT flux was measured by photoconverting from green to red fluorescence two bar-like regions on each side of the mitotic spindle and following their poleward movement over time (Figure 5a , Supplementary videos S5 and S6). Interestingly, we found that EGFP-Hec1 expression significantly decreased flux to 0.55 ± 0.04 μm/min, as compared with 0.83 ± 0.05 μm/min in Hec1-EGFP-expressing cells (Po0.001, Figure 5b ). This suggested that KT-MT interactions were stabilized by the EGFP-Hec1 presence and that this stabilization impaired plus-end tubulin polymerization required for fluorescent mark translocation. In parallel experiments, MT turnover was determined by measuring the fluorescence decay rate of photoactivated mEos-tubulin over time. Data were fitted to a double exponential curve (coefficient of determination R 2 40.99 in both cases) in which the slower-decay component corresponds to the more stable KT-MT fibres in which the activated fluorescence is more persistent. 29 In agreement with the flux data, the calculated half-time of KT-MTs was significantly longer in EGFP-Hec1 than in Hec1-EGFP-expressing cells (340.97 ± 63.89 vs 196.73 ± 20.41 s, Po0.05; Figure 5c ). These results demonstrate an increased KT-MT attachment stability in EGFP-Hec1-expressing cells and provide a molecular explanation for the occurrence of mitotic arrest and multipolar spindles. Accordingly, stabilization of KT-MT attachments on bi-oriented chromosomes increases MT-based forces generated at KTs, causing cohesion fatigue and centromere splitting. 26, 27 Single chromatids then destabilize KT-MT end-on attachments due to the lack of tension and establish persistent KT-MT lateral attachments that lead to loss of spindle pole integrity. 19 EGFP-Hec1 expression produces no significant effects on normal human cells Next, we extended our phenotype analysis by expressing EGFP-Hec1 in normal cells. To this aim, we created a human fibroblast MRC-5 cell line expressing EGFP-Hec1 upon doxycycline induction, by taking advantage of a piggyBac transposon-derived vector that stably integrates into the genome. 31, 32 Cell growth, cell cycle progression and cell death of human fibroblasts were not significantly affected by EGFP-Hec1 expression, as opposed to HeLa cells (Figures 6a and b ). Absence of cell death correlated well with the low frequency of chromosome segregation and spindle defects (Figure 6c ). Western blotting analysis showed that EGFP-Hec1 was expressed in MRC-5 cells at levels slightly higher than those of HeLa cells (Supplementary Figure S3 ), possibly reflecting the integration of the transgene at more than one insertion site by this transposon-mediated strategy. 33 In any case, the modified protein correctly localized at KTs in mitotic cells (Figure 6d ). The capacity of EGFP-Hec1 to produce cell death exclusively in tumour cells was further confirmed by comparing MCF 10A and MDA-MB-231 cells, two epithelial cell lines from breast tissue at different transformation states. In both cell lines, EGFP-Hec1 was expressed at comparable levels and localized to KTs, but only metastatic MDA-MB-231 cells died (Supplementary Figure S4) . Overall, these findings demonstrate that tumour cells are more sensitive to the expression of the modified Hec1 protein compared with untransformed cells.
EGFP-Hec1 expression inhibits tumour growth in a xenograft mouse model
To test whether inducible Hec1 expression has the ability to inhibit tumour growth in a xenograft mouse model, we inoculated nude mice with the engineerized HeLa cells and induced EGFP-Hec1 expression by administration of doxycycline in the drinking water. Continuous expression of EGFP-Hec1 from day 7 after cell injection until killing (+doxy) induced a complete tumour regression in 50% of mice that were free of tumours at the end of the experiment (35 days after cell injection); in the remaining animals, growth was abolished so that tumour volume did not increase from day 7 to day 35 (Figures 7a and b) . A very effective reduction of tumour growth was also observed when EGFP-Hec1 expression was activated at day 17 from cell injection (+doxy late, Figure 7b ), with complete tumour regression in 20% of mice belonging to this group. When EGFP-Hec1 activation from day 7 was followed by doxycycline elimination at day 16 (+doxy early), tumour growth was inhibited during EGFP-Hec1 expression and resumed after doxycycline removal (Figure 7b ), indicating that proliferation-inhibiting effects of EGFP-Hec1 were dependent on doxycycline induction and were reversible upon its withdrawal. Protein analysis on tumour tissues excided at killing demonstrated that EGFP-Hec1 expression could be achieved also in vivo and that the presence of the modified protein was entirely dependent on doxycycline induction (Figure 7c ). In agreement with the in vitro findings, expression of Hec1-EGFP did not affect tumour growth in the same mouse model (Supplementary Figure S5) .
Tumours were subsequently dissected, sectioned and stained for histopathology and immunohistochemistry. EGFP-Hec1expressing xenografts showed an elevated incidence of mitotic and apoptotic cells when compared with uninduced xenografts in haematoxylin and eosin-stained slides (Figure 7d ). Interestingly, inspection at higher magnification of mitoses in EGFP-Hec1expressing tumours showed that they consisted of mitotic cells in which the chromosomes were grouped in several clusters, a chromosome organization which is highly indicative of a chromosome arrangement within a multipolar spindle (insets in Figure 7d ). On the contrary, chromosomes were found to correctly congress within a single metaphase plate in mitotic cells from uninduced tumours (insets in Figure 7d ). Quantitative analyses of these samples demonstrated a highly significant increase in the frequency of mitosis for all doxycycline treatments (Figure 7f ) together with a strong induction of aberrant mitoses only in the two groups of animals that were receiving doxycycline at killing (Figure 7g ). Analysis of apoptosis by terminal deoxynucleotidyl transferase (TdT)-mediated nick end labeling staining (TUNEL) staining ( Figure 7e ) revealed a significant increase in the percentage of apoptotic tumour cells for all doxycycline treatments (Figure 7h ), suggesting that mitosis disruption by EGFP-Hec1 expression produced long-term effects on cell viability. Finally, Ki67 positivity was not affected by EGFP-Hec1 expression (Figure 7i ), indicating that EGFP-Hec1 effects on tumour growth were targeted to mitosis, while other cell cycle processes were unaffected. Thus these findings demonstrate that massive chromosome missegregation and cancer cell death can be obtained in vivo upon EGFP-Hec1 expression.
DISCUSSION
The KT protein Hec1 is highly expressed in most malignancies and is supposed to have a key role in the survival of neoplastic cells by regulating chromosome segregation. [10] [11] [12] Accordingly, a recent work performing an high-throughput lethality RNAi screen of 6 000 genes in a panel of ovarian cell lines has identified HEC1 as one of the four genes required for the survival of cancer cells. 34 Here we show that expression of a N-terminally modified Hec1 completely abolishes in vitro growth of HeLa cells and almost abrogates tumour growth in xenografted mice. These findings demonstrate that regulated Hec1 function is essential for proper chromosome segregation of cancer cells and that this KT protein represents a good target for halting proliferation and triggering cell death in the same cells.
In both in vitro and in vivo models, EGFP-Hec1-expressing cells were arrested in mitosis and produced multipolar spindles. Live imaging of expressing cells demonstrated that impaired chromosome segregation within multipolar spindles promotes apoptotic death from mitosis or gives rise to extremely abnormal multinucleated cells and to cytokinesis failure. These different outcomes are all morphological signs of mitotic catastrophe 28 and demonstrate that stimulation of massive chromosome missegregation through the formation of multipolar spindles can be used as an anti-cancer strategy through the activation of mitotic catastrophe. The efficacy of EGFP-Hec1 expression in producing mitotic catastrophe and thereby killing tumour cells renders this approach much more promising in comparison with the use of classical anti-tubulin agents or Hec1 depletion by siRNA. The mitotic defects elicited by those treatments derive from a checkpoint-dependent mitotic arrest, which originates either from defective spindle assembly (anti-tubulin drugs) or from a lack of KT-MT interactions (Hec1 siRNA). Cells arrested in mitosis by these means are then potentially subjected to a mitotic slippage process in which spontaneous cyclin B degradation drives mitotic exit without chromosome segregation and produces chromosomally unstable G1 tetraploid cells. 35, 36 To overcome these drawbacks of checkpoint-mediated anti-mitotic therapies, inhibition of mitotic exit by Cdc20 knockdown to indefinitely maintain mitotic arrest 37 or inhibition of centrosome coalescence in cancer cells possessing supernumerary centrosomes 18, 38 have been recently proposed as alternative strategies for cancer cell killing by promoting massive apoptosis in mitosis. Expression of EGFP-Hec1 may represent a novel tool to obtain cell death through the activation of mitotic catastrophe also in cancer cells possessing two centrosomes. 39 Importantly, expression of the modified Hec1 in normal human cells did not influence their in vitro proliferation in conditions that produced massive mitotic catastrophe in cancer cells. This finding strongly suggests that a window of opportunity exists to selectively kill tumour cells by expressing the modified Hec1 and deserves further experimentation in the framework of prospective clinical studies. We previously demonstrated that Hec1 protein levels and KT recruitment are significantly elevated in several cancer cell lines in comparison with normal ones. 13 Those findings, together with the present data, provide a sound basis for developing a more rational, personalized approach to cancer treatment by developing strategies based on altering Hec1 affinity to MTs in tumours showing high Hec1 expression. In the course of the past years, significant progress has been made in using genetic information to individually tailor the application of DNA-damaging agents in cancer therapy. 40 Similarly, the work described here suggests that mitotic characteristics of tumour cells might be used to individualize anti-mitotic gene therapies or drugs.
It should be recognized that proofs of concept for the use of genetic approaches targeted to mitotic proteins, such as RNAibased depletion of mitotic kinases, 41 have been obtained in vitro and in vivo in the past years, but only a few of them have been translated into therapy. Overall, the clinical success rate has been disappointing, and it is generally concluded that the gene therapy of cancer requires more innovation before its potential can be fully realized. However, the very recent development of innovative approaches using lentiviral vectors designed for tissue or cell targeting 42, 43 and the ongoing efforts on the construction of nanoparticles from different materials [44] [45] [46] provide new tools for efficient and safe in vivo gene delivery. Consistently, evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles has been reported, 47, 48 strongly supporting the urgent need for a new reappraisal of the gene therapy of cancer. In this scenario, targeting a KT protein essential for chromosome segregation through specific gene modifications may represent a powerful strategy to selectively kill tumour cells.
From a mechanistic point of view, the work presented here demonstrates that stabilization of KT-MT attachment dynamics promotes cancer cell death through spindle multipolarity driving aberrant chromosome segregation. This finding is in accordance with the data showing that maintenance of spindle bipolarity depends on a fine balance of chromosome-and centrosomeassociated forces, so that spindle-pole integrity is influenced by KT activity. 19, 49, 50 The results presented here suggest that Hec1 N-terminus constitutes a promising target in anti-cancer studies, due to its function in controlling KT-MT dynamics. Investigating different modifications of the Hec1 N-terminal tail may open new possibilities to enhance chromosome missegregation by modulating KT-MT attachment dynamics. More importantly, the present work indicates that interfering with KT-MT dynamics by targeting the molecular machineries involved in its regulation [5] [6] [7] [8] 51 and in the correction of KT-MT misattachments [4] [5] [6] 52 may open new avenues in the development of anti-cancer strategies. Interestingly, recent data have demonstrated that chromosomally unstable tumour cells display hyperstable KT-MT attachments and are therefore defective in correcting errroneous KT-MT attachment. 53 Concordantly, stimulation of MT dynamics at KTs restores stability to chromosomally unstable tumour cell lines, suggesting a narrow interval of KT-MT dynamics for accurate chromosome segregation. 7, 8, 53 Here we propose that a further stabilization of KT-MT attachments in chromosomally unstable cancer cells may produce cancer cell death through massive chromosome missegregation.
In conclusion, this study provides a clear proof of concept that modifying KT-MT attachment stability may represent a promising instrument to promote spindle multipolarity, massive chromosome missegregation and cancer cell death. Interestingly, a recent study has shown that the citotoxic effects of the MT-stabilizing drug taxol, a widely used therapeutic drug, are associated with mitotic spindle multipolarity and abnormal anaphase segregation in human breast cancer tissues, highlighting the relevance of KT-MT stabilization in producing cancer cell death through spindle multipolarity in tumour patients. 54 
MATERIALS AND METHODS
Cell culture, HeLa transgene expression and RNAi
Doxycycline-inducible stable HeLa cell lines were created as previously described using the Flp-In technology (Invitrogen, Carlsbad, CA, USA). 19 Clonal cell cultures were grown in Dulbecco's modified Eagle's medium supplemented with 10% foetal bovine serum (Clontech, Montain View, CA, USA), 1% L-Glutamine and antibiotics at 37°C. To obtain EGFP-Hec1 expression 4 × 10 5 cells were seeded in 60-mm dishes and received 0.02 μg/ml doxycycline (Sigma-Aldrich, St Louis, MO, USA) 24 h later. In silencing experiments, cells received a 20-nM mixture of two different siRNA targeting HEC1 22,55 or 20 nM of a control siRNA against firefly luciferase by Lipofectamine 2000 (Invitrogen).
Plasmid construction and generation of a stable MRC-5 human fibroblast line
The epB-Puro-TT-EGFP-HEC1-mut plasmid was generated by inserting a siRNA-resistant EGFP-HEC1 sequence in the enhanced piggyBac transposable vector epB-Puro-TT. 32 The resulting construct contains the piggyBac terminal repeats flanking a constitutive cassette driving the expression of the Puromycin resistance gene fused to the rtTA gene and, in the opposite direction, a tetracycline-responsive promoter element driving the expression of EGFP-Hec1. MRC-5 cells were co-transfected with 4 μg epB-Puro-TT-siRNA-resistant EGFP-HEC1 and 1 μg of the piggyBac transposase using the Neon Transfection System (Life Technologies, Carlsbad, CA, USA). Selection in 1μg/ml puromycin gave rise to a stable and inducible cell line.
Cell viability assays
Cells were harvested at different times after doxycycline or siRNA addition, and viable cells were counted by trypan blue exclusion. At the same harvesting times, cell cycle progression and apoptosis were evaluated by flow cytometry on an Epics XL apparatus (Beckman Coulter, Galway, Ireland) using propidium iodide staining. Ten thousand events were collected from each sample.
Immunoblotting
Western blotting experiments were performed as previously described. 19 Briefly, cells were lysed in radioimmunoprecipitation assay buffer, protein content was determined by Bradford reagent and 40 μg of total proteins were resolved in 4-12% gradient gels by sodium dodecyl sulphatepolyacrylamide gel electrophoresis. Proteins were transferred onto nitrocellulose membranes and incubated with mouse anti-Hec1 (9G3, AbCam, Cambridge, UK), goat anti-actin (Santa Cruz Biotechnology, Santa Cruz, CA, USA), rabbit anti-cleaved caspase-3 (Cell SignalingTechnology, Danvers, MA, USA) or rabbit anti-PARP (Roche, Penzberg, Germany) antibodies. The membranes were subsequently probed with the appropriate horseradish peroxidase-conjugated secondary antibodies (Santa Cruz Biotechnology), and antigens on the membrane were revealed by enhanced chemiluminescence (ECL plus, GE Healthcare, Buckingamshire, UK).
Immunofluorescence
Cells were rinsed in PHEM (60 mM PIPES, 25 mM Hepes, 10 mM EGTA, 2 mM MgCl 2 ) buffer, fixed for 15 min with 3.7% formaldehyde in PHEM, permeabilized 5 min in 0.3% Triton X-100 and postfixed in cold methanol for 3 min. Coverslips were processed for immunofluorescence using fluorescein isothiocyanate-conjugated anti-α-tubulin (Sigma-Aldrich) and mouse anti-Hec1 (AbCam) antibodies in uninduced samples or a mouse αtubulin antibody in EGFP-Hec1-expressing cells. DNA was counterstained by DAPI (4,6-diamidino-2-phenylindole). Preparations were examined under an Olympus AX70 microscope (Olympus, Tokyo, Japan) using a × 100/1.35 NA objective. Images were acquired using a SPOT chargecoupled device camera (Diagnostic Instruments, Sterling Heights, MI, USA) controlled by the ISO 2000 software (DeltaSistemi, Rome, Italy) and processed using Adobe Photoshop 7.0 (Adobe Systems Incorporated, San Jose, CA, USA).
Live-cell imaging
Cells were seeded in 35-mm dishes (81156, ibiTreat, Ibidi, Martinsried, Germany) and transfected with a H2B-GFP-expressing construct. Six hours later, the medium was replaced with fresh medium containing 0.2 μg/ml doxycycline, and time-lapse observation was started 24 h later. Cells were recorded under an Eclipse Ti inverted microscope (Nikon, Tokyo, Japan), using a Plan Fluor × 40, 0.6 NA objective (Nikon); during the whole observation, cells were kept in a microscope stage incubator (Basic WJ, Okolab, Ottaviano, Italy) at 37°C and 5% CO 2 . Images were acquired over 24 h using a DS-Qi1Mc camera and the NIS-Elements AR 3.22 software (Nikon). Images were taken every 3 (differential contrast interference) or 6 (H2B-GFP) min for the initial 6 h and then every 30 min. Videos and still images were processed using the NIS-Elements AR 4.0 and Photoshop 7.0 software.
MT flux and KT-MT turnover
Cells were cultivated on glass-bottomed dishes (MatTek Corporation, Ashland, MA, USA) and transfected with a mEos-tubulin vector (kindly provided by S Geley, Biocenter, Innsbruck Medical University, Innsbruck, Austria). After 24 h, cells were induced to express the modified Hec1 proteins, and imaging was started 24 h later. Imaging was performed as previously described. 56 Briefly, late prometaphase/metaphase cells were identified upon green fluorescence and two thin rectangular photoactivation regions were placed perpendicular to the main spindle axis on both sides of the chromosome plate. After photo-conversion by pulsed UV-irradiation, red and green signals were followed over time by acquiring a stack of five Z planes for each fluorescence every 15 s for 2 min. MT flux was quantified by tracking photo-converted mEos-tubulin signals over time using an algorithm written in Matlab programming language. Measured distances between peaks over time were then used to calculate the average MT poleward velocity by linear fitting. In MT turnover assay, a single region was placed to one half-spindle, and background was subtracted using an equal area from the non-activated half spindle. MT turnover was quantified by measuring integrated pixel intensities within the photo-converted area, acquiring a stack of five Z planes for each fluorescence every 15 s over a 5-min time interval. Photo-bleaching correction was done by normalization to the average curve obtained upon photo-conversion of Taxol-treated spindles (5 μM, added 20 min before imaging). Background-subtracted and normalized fluorescence of different cells was averaged at each time point, and double exponential fitting was performed. 56 
Tumour xenografts in nude mice
In all, 5 × 10 6 doxycycline-inducible EGFP-Hec1 HeLa cells were subcutaneously injected into 8-week-old male immunodeficient athymic mice
